The discovery to commercialization process has always been lengthier for pharmaceuticals and biotechnological companies. The various reasons are research and development, regulatory compliance, intellectual property…
Category: Uncategorized
The Rise of High Potent APIs: Trends, Technologies, and Manufacturing Best Practices
The latest reports from the Centers for Disease Control and Prevention (CDC) suggest that the number of people suffering from cardiovascular disease, diabetes, and cancer…
CDMO Innovations: Advancing Pharma Manufacturing with Chemical Development Solutions From Early To Late Phase
Chemistry development solutions have been playing an important role in the drug discovery and development cycle by offering unique and process-oriented one-stop solutions from discovery…